Naga Raja

Ferritin Normalization Is Not Disease Control in HFE ‐Related Hemochromatosis: Residual Risk, Transferrin Saturation, and the Hepcidin–Ferroportin Axis

ABSTRACT HFE ‐related hemochromatosis is conventionally managed as a disorder of iron excess, with therapeutic phlebotomy as effective, inexpensive, first‐line therapy. Ferritin normalization, however, may not fully capture clinical burden. Delphi consensus data identify the lack...